Review our
Clinical Trials
Learn more about our ongoing clinical trials.
Closed to enrollment
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Maintenance of Efficacy of Ecopipam in Children, Adolescents and Adults With Tourette’s Disorder
Closed to enrollment
A Multicenter, Open-Label, Extension Study Intended to Evaluate the Long-term Safety of Ecopipam Tablets in Children and Adolescent Subjects With Tourette’s Syndrome
Closed to enrollment
A Multicenter, Open-Label, Study to Evaluate the Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette’s Disorder
Closed to enrollment
Multicenter, Placebo-Controlled, Double-Blind, Randomized, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Ecopipam in Children and Adolescents With Tourette’s Syndrome
Related Links
Are you a healthcare professional?
You must be a healthcare professional to view this page. By clicking “Yes”, you are confirming you are a healthcare professional.
This portal is intended to help healthcare professionals in the United States and its territories find scientifically balanced information related to Emalex compounds or products, including clinical data and research developments. The site is made available by Emalex’s Medical Affairs organization, a part of Emalex Biosciences, and is provided as a scientific resource for informational, non-promotional purposes.
Emalex does not have any approved products. Medical information provided on this site, related to our research areas, pertain to investigational drugs that have not been determined to be safe and effective for any disease or condition. The content of this site is not medical advice and does not replace independent medical judgment. Healthcare providers are responsible for individual patient care on the basis of their professional knowledge, experience, and licensure.
Emalex does not have any approved products. Medical information provided on this site, related to our research areas, pertain to investigational drugs that have not been determined to be safe and effective for any disease or condition. The content of this site is not medical advice and does not replace independent medical judgment. Healthcare providers are responsible for individual patient care on the basis of their professional knowledge, experience, and licensure.
You are leaving the Emalex Medical Affairs website and transferring to a separate site administered by Emalex.
You Will Be Redirected In 5... If you aren't automatically redirected, please click here.